Intrinsic Value of S&P & Nasdaq Contact Us

Enhabit, Inc. EHAB NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
27/100
0/7 Pass
SharesGrow Intrinsic Value
$9.47
-32.1%
Analyst Price Target
$13.53
-2.9%

Enhabit, Inc. (EHAB) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 2 Buy, 8 Hold, 1 Sell.

The consensus price target is $13.53 (low: $12.00, high: $14.00), representing a downside of 2.9% from the current price $13.94.

Analysts estimate Earnings Per Share (EPS) of $0.22 and revenue of $1.04B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-3.11 vs est $0.22 (missed -1496.4%). 2025: actual $-0.09 vs est $0.56 (missed -116.1%). Analyst accuracy: 0%.

EHAB Stock — 12-Month Price Forecast

$13.53
▼ -2.94% Downside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Enhabit, Inc., the average price target is $13.53, with a high forecast of $14.00, and a low forecast of $12.00.
The average price target represents a -2.94% change from the last price of $13.94.
Highest Price Target
$14.00
Average Price Target
$13.53
Lowest Price Target
$12.00

EHAB Analyst Ratings

Hold
11
Ratings
2 Buy
8 Hold
1 Sell
Based on 11 analysts giving stock ratings to Enhabit, Inc. in the past 3 months
Rating breakdown
Buy
2 18%
Hold
8 73%
Sell
1 9%
18%
Buy
2 analysts
73%
Hold
8 analysts
9%
Sell
1 analysts

EPS Estimates — EHAB

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$3.11 vs Est $0.22 ▼ 107.2% off
2025 Actual –$0.09 vs Est $0.56 ▼ 721.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect the company to turn profitable.

Revenue Estimates — EHAB

100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $1.035B vs Est $1.036B ▼ 0.1% off
2025 Actual $1.060B vs Est $1.060B ▼ 0.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message